Elisabetta Rovida

2.6k total citations
78 papers, 2.0k citations indexed

About

Elisabetta Rovida is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Elisabetta Rovida has authored 78 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 22 papers in Hematology and 17 papers in Cancer Research. Recurrent topics in Elisabetta Rovida's work include Chronic Myeloid Leukemia Treatments (14 papers), Melanoma and MAPK Pathways (13 papers) and Acute Myeloid Leukemia Research (13 papers). Elisabetta Rovida is often cited by papers focused on Chronic Myeloid Leukemia Treatments (14 papers), Melanoma and MAPK Pathways (13 papers) and Acute Myeloid Leukemia Research (13 papers). Elisabetta Rovida collaborates with scholars based in Italy, United States and France. Elisabetta Rovida's co-authors include Persio Dello Sbarba, Barbara Stecca, Ignazia Tusa, V Barbetti, Maria Grazia Cipolleschi, Antonella Gozzini, Mario Del Rosso, Massimo Olivotto, Jacques J. Peschon and Andrea Morandi and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Elisabetta Rovida

77 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabetta Rovida Italy 28 1.1k 419 395 392 365 78 2.0k
Maria Luisa Sulis United States 19 2.2k 2.0× 399 1.0× 638 1.6× 764 1.9× 367 1.0× 52 3.2k
Luca Zammataro Italy 18 1.2k 1.1× 867 2.1× 665 1.7× 167 0.4× 293 0.8× 39 2.4k
Minji Jo United States 23 1.6k 1.5× 444 1.1× 796 2.0× 239 0.6× 902 2.5× 33 2.5k
Valeria Ossovskaya United States 18 1.1k 1.0× 242 0.6× 916 2.3× 663 1.7× 487 1.3× 31 2.4k
Francesca Fazioli Italy 22 1.1k 1.0× 255 0.6× 577 1.5× 320 0.8× 727 2.0× 48 2.1k
Deniz Toksoz United States 30 1.8k 1.7× 458 1.1× 459 1.2× 463 1.2× 204 0.6× 49 2.9k
Jasper de Boer United Kingdom 22 1.2k 1.1× 787 1.9× 342 0.9× 477 1.2× 271 0.7× 43 2.2k
Stacey J. Baker United States 18 1.3k 1.2× 547 1.3× 615 1.6× 343 0.9× 381 1.0× 34 2.3k
Alison M. Michie United Kingdom 27 1.2k 1.2× 1.0k 2.5× 486 1.2× 463 1.2× 304 0.8× 67 2.5k
Delphine Garnier Canada 26 1.3k 1.3× 218 0.5× 329 0.8× 179 0.5× 828 2.3× 44 2.1k

Countries citing papers authored by Elisabetta Rovida

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Rovida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Rovida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Rovida more than expected).

Fields of papers citing papers by Elisabetta Rovida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Rovida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Rovida. The network helps show where Elisabetta Rovida may publish in the future.

Co-authorship network of co-authors of Elisabetta Rovida

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Rovida. A scholar is included among the top collaborators of Elisabetta Rovida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Rovida. Elisabetta Rovida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martella, Daniele, Ignazia Tusa, Armando Negri, et al.. (2025). Liquid Crystalline Networks Hamper the Malignancy of Cancer Cells. Advanced Healthcare Materials. 14(7). e2403607–e2403607. 1 indexed citations
2.
Schiavone, Nicola, et al.. (2025). Exploring the Gut Microbiota–Retina Axis: Implications for Health and Disease. Microorganisms. 13(5). 1101–1101. 6 indexed citations
3.
Gardini, Lucia, Matteo Lulli, Ignazia Tusa, et al.. (2024). Importin subunit beta‐1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation. Molecular Oncology. 19(1). 99–113. 3 indexed citations
4.
Tusa, Ignazia, Francesca Cencetti, Silvia Vannuccini, et al.. (2023). Sphingosine 1‐phosphate elicits a ROS‐mediated proinflammatory response in human endometrial stromal cells via ERK5 activation. The FASEB Journal. 37(8). e23061–e23061. 8 indexed citations
5.
Tusa, Ignazia, et al.. (2023). Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress. Cells. 12(8). 1154–1154. 11 indexed citations
6.
Foglia, Beatrice, Salvatore Sutti, Stefania Cannito, et al.. (2021). Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation. Cellular and Molecular Gastroenterology and Hepatology. 13(2). 459–482. 18 indexed citations
7.
Peppicelli, Silvia, Ignazia Tusa, Giulia Cheloni, et al.. (2021). Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell Potential. Cancers. 13(17). 4372–4372. 6 indexed citations
8.
Tusa, Ignazia, Sinforosa Gagliardi, Matteo Lulli, et al.. (2021). Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21. Cancer Research. 82(3). 447–457. 29 indexed citations
9.
Tusa, Ignazia, et al.. (2020). Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy. International Journal of Molecular Sciences. 21(3). 938–938. 29 indexed citations
10.
Maira, Giovanni Di, Alessandra Gentilini, Mirella Pastore, et al.. (2019). The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells. Oncogenesis. 8(11). 61–61. 30 indexed citations
11.
Gentilini, Alessandra, Alessandra Caligiuri, Chiara Raggi, et al.. (2019). CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(9). 2246–2256. 16 indexed citations
12.
Cheloni, Giulia, Erico Masala, Nathalie M. Mazure, et al.. (2017). The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction. Stem Cells International. 2017. 1–8. 17 indexed citations
13.
Cheloni, Giulia, Michele Tanturli, Ignazia Tusa, et al.. (2017). Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. Blood. 130(5). 655–665. 69 indexed citations
14.
Cipolleschi, Maria Grazia, Ilaria Marzi, Elisabetta Rovida, & Persio Dello Sbarba. (2016). Chronic Myeloid Leukemia and Hepatoblastoma: Two Cancer Models to Link Metabolism to Stem Cells. Frontiers in Oncology. 6. 95–95. 2 indexed citations
15.
Cannito, Stefania, Cristian Turato, Claudia Paternostro, et al.. (2014). Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. Oncotarget. 6(4). 2206–2221. 47 indexed citations
16.
Rovida, Elisabetta, Giovanni Di Maira, Ignazia Tusa, et al.. (2014). The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. Gut. 64(9). 1454–1465. 54 indexed citations
17.
Barbetti, V, Ignazia Tusa, Maria Grazia Cipolleschi, Elisabetta Rovida, & Persio Dello Sbarba. (2013). AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia. Cell Death and Disease. 4(3). e536–e536. 21 indexed citations
18.
Rovida, Elisabetta, Elena Spinelli, Sara Sdelci, et al.. (2008). ERK5/BMK1 Is Indispensable for Optimal Colony-Stimulating Factor 1 (CSF-1)-Induced Proliferation in Macrophages in a Src-Dependent Fashion. The Journal of Immunology. 180(6). 4166–4172. 53 indexed citations
19.
20.
Rovida, Elisabetta, Fabio Marra, Manuela Baccarini, & Persio Dello Sbarba. (2000). Constitutive activation of the MAPK pathway mediates v-fes–induced mitogenesis in murine macrophages. Blood. 95(12). 3959–3963. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Luisa Sulis Breakdown of academic impact, for papers by Luca Zammataro Breakdown of academic impact, for papers by Minji Jo Breakdown of academic impact, for papers by Valeria Ossovskaya Breakdown of academic impact, for papers by Francesca Fazioli Breakdown of academic impact, for papers by Deniz Toksoz Breakdown of academic impact, for papers by Jasper de Boer Breakdown of academic impact, for papers by Stacey J. Baker Breakdown of academic impact, for papers by Alison M. Michie Breakdown of academic impact, for papers by Delphine Garnier
Rankless by CCL
2026